{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F2a2c2fe2-09a8-435e-b24d-9c07220c6366","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Bispecific Antibodies in the Management of Lymphoma \u2014 ASH 2025 Review\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/2a2c2fe2-09a8-435e-b24d-9c07220c6366\"></iframe>","title":"Bispecific Antibodies in the Management of Lymphoma \u2014 ASH 2025 Review","description":null,"thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png"}